Kimura K, Moriya H
Histochemistry. 1984;80(5):443-8. doi: 10.1007/BF00495432.
Localization of kallikrein in the human kidney was investigated by two markers: kallikrein-like activity and kallikrein antigenicity. Kallikrein-like activity was demonstrated enzyme-histochemically by using a synthetic substrate for kallikrein, pro-phe-arg-naphthyl-ester. Kallikrein antigenicity was demonstrated by the unlabelled antibody peroxidase-antiperoxidase method using an antiserum against human urinary kallikrein. The kallikrein-like activity was localized in the proximal tubular cells without any corresponding kallikrein antigenicity. Neither kallikrein-like activity nor kallikrein antigenicity was noticed in any other tubular cell. These results are contrary to those in the ductal cells of the human parotid gland where the kallikrein-like activity and the kallikrein antigenicity were identical in their locations. The peroxidase-antiperoxidase method revealed, for the first time, kallikrein antigenicity both in the interstitium and in the basement membrane region of Bowman's capsule and of all the tubules, possibly representing circulating glandular kallikreins deposited in the renal tissue. Thus, the present findings are consistent with the hypothesis that the urinary (renal) kallikreins are derived from circulating glandular kallikreins.
激肽释放酶样活性和激肽释放酶抗原性。通过使用激肽释放酶的合成底物——脯氨酸 - 苯丙氨酸 - 精氨酸 - 萘酯,采用酶组织化学方法显示激肽释放酶样活性。使用抗人尿激肽释放酶抗血清,通过未标记抗体过氧化物酶 - 抗过氧化物酶法显示激肽释放酶抗原性。激肽释放酶样活性定位于近端肾小管细胞,而无相应的激肽释放酶抗原性。在任何其他肾小管细胞中均未发现激肽释放酶样活性和激肽释放酶抗原性。这些结果与人类腮腺导管细胞中的结果相反,在腮腺导管细胞中激肽释放酶样活性和激肽释放酶抗原性在位置上是相同的。过氧化物酶 - 抗过氧化物酶法首次揭示了在间质以及鲍曼囊和所有肾小管的基底膜区域中存在激肽释放酶抗原性,这可能代表沉积在肾组织中的循环腺激肽释放酶。因此,本研究结果与尿(肾)激肽释放酶源自循环腺激肽释放酶这一假说一致。